Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...
systemic delivery of these vectors remains a major hurdle that has stymied gene therapy applications. But there’s movement. In May 2019, a team led by Luigi Naldini and Alessio Cantore ...
Safety Concerns: The use of viral vectors carries risks such as immune ... promise for improving precision and expanding therapeutic applications. Gene therapy represents a paradigm shift in ...
The "AAV Vectors in Gene Therapy - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.The Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline signifies a ...
The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...
Yet, despite these successes, the wider application of AAV-based gene therapies remains limited due to the complex interaction of the AAV vectors with a patient’s immune system. Chameleon’s ...